Home
>
National Drug Code (NDC)
>
Mycobutin
Mycobutin - 0013-5301-17 - (rifabutin)
Drug Information of Mycobutin
| Product NDC: | 0013-5301 |
| Proprietary Name: | Mycobutin |
| Non Proprietary Name: | rifabutin |
| Active Ingredient(s): | 150 mg/1 & nbsp; rifabutin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mycobutin
| Product NDC: | 0013-5301 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050689 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19921223 |
Package Information of Mycobutin
| Package NDC: | 0013-5301-17 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0013-5301-17) |
NDC Information of Mycobutin
| NDC Code | 0013-5301-17 |
| Proprietary Name | Mycobutin |
| Package Description | 100 CAPSULE in 1 BOTTLE (0013-5301-17) |
| Product NDC | 0013-5301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rifabutin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19921223 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | RIFABUTIN |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] |
